A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The primary objective of this study is to evaluate the pharmacokinetics (PK) and tolerability of tralokinumab when delivered subcutaneously at different flow rates to healthy volunteers.
Epistemonikos ID: 8afebee0f6f49741645ce16e75d40af57c17c0a5
First added on: May 11, 2024